Investigation of serum biomarker for prediction of efficacy of the treatments for inflammatory bowel disease - Biomarker for IBD

Osaka University Graduate School of Medicine0 个研究点目标入组 129 人开始时间: 2014年6月6日最近更新: 2023年10月17日

研究概览

简要总结

In patients with inflammatory bowel diseases (IBD), alterations of oligosaccharide structures of IgA or IgG can serve as diagnostic biomarkers of IBD. Serum leucine-rich alpha-2 glycoprotein was associated with clinical and endoscopic activity of IBD and can serve as a new biomarker for monitoring disease activity of IBD.

研究设计

研究类型: Observational

入排标准

年龄范围: 16years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•1) Patients with mental diseases 2) Patients younger than 16 years old. 3) Patients who are not suitable to attend this study judged by physicians.

研究者

发起方

Osaka University Graduate School of Medicine

相似试验

招募中

不适用

Predictive biomarkers for inflammatory bowel disease-associated dysplasiaDysplasia1001796910017991Cancer

NL-OMON51848Amsterdam UMC2,000

已完成

不适用

Research for biomarkers of inflammatory bowel disease. - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments

JPRN-UMIN000019958Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine80

招募中

不适用

IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASEInflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis

NCT03809728Central Hospital, Nancy, France1,000

已完成

不适用

Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution CapacitiesInflammatory Bowel Diseases

NCT01216514Centre Hospitalier Universitaire de Saint Etienne194

终止

不适用

Inflammatory Bowel Disease(IBD), Treatment ResponseInflammatory Bowel DiseasesUlcerative ColitisCrohn Disease

NCT05350644University of Southern Denmark2